Myriad Genetics, Inc. - Common Stock — Cash Flow (NASDAQ:MYGN) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Documents

Quarterly Annual

Cash from operating activities 18.2 M-106.3 M-110.9 M-8.7 M1.8 M 79 M Cash from investing activities 274.4 M-77.5 M31.9 M-11.9 M-27.4 M — Cash from financing activities -150.6 M-8 M152.9 M-7.4 M64.2 M — Free cash flow 200 K-151.6 M-110.9 M-8.7 M-10 M 73.2 M

News

Myriad Genetics: Strong Oncology Demand, But Monetization Breaks Down (NASDAQ:MYGN)

Myriad Genetics, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:MYGN) 2026-08-01

Myriad Genetics (MYGN) Reports Q2 Loss, Misses Revenue Estimates

3 Promising Genomics Stocks to Add to Your Portfolio in 2026

AWHL vs. MYGN: Which Women's Health Diagnostics Stock is Better Now?

Is This the Right Time to Hold MYGN Stock in Your Portfolio?

Myriad (MYGN) Soars 8.3%: Is Further Upside Left in the Stock?

Should You Add Myriad Genetics Stock to Your Portfolio Right Now?

Myriad (MYGN) Up 7.1% Since Last Earnings Report: Can It Continue?

3 Promising Genomics & Synthetic Biology Stocks in Spotlight in 2026

Myriad Genetics' Upcoming Prolaris + AI Test Debut May Lift Its Stock

Is MYGN Stock a Buy at 0.4x Sales? What Investors Should Weigh